Submit Your Feeds

Business News • PR NewsWire • BioVentrix announces the 1st Revivent TC™ TransCatheter commercial procedure to treat Ischemic Cardiomyopathy in China

BioVentrix announces the 1st Revivent TC™ TransCatheter commercial procedure to treat Ischemic Cardiomyopathy in China
BioVentrix announces the 1st Revivent TC™ TransCatheter commercial procedure to treat Ischemic Cardiomyopathy in China

SAN RAMON, Calif., and XIAMEN, China, March 13, 2017 /PRNewswire/ -- BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced commercialization and the first clinical use of its closed-chest Revivent TC™ System in the...

View More : http://www.prnewswire.com/news-releases/bioventrix-announces-the-1st-revivent-tc-transcatheter-commercial-procedure-to-t...
Releted News by prnewswire
Jumeirah Central Makes International Debut at MIPIM 2017, World’s Leading Property Show
Leuphana University Inaugurates Libeskind Building
Novus Aqua Academy: Map Out Strategy to Win in the Blue Ocean
BioVentrix announces the 1st Revivent TC™ TransCatheter commercial procedure to treat Ischemic Cardiomyopathy in China
CECEP Solar Energy Technology（Zhenjiang）Co.,Ltd und RCT Solutions GmbH unterzeichnen Zusammenarbeitsvereinbarung über schwarzes Silicium
Global Teleradiology Market - Forecast & Analysis to 2022 - Drivers, Restraints, Opportunities, Threats, Challenges & Opportunities - Research and Markets
Home Sitemap Contact Us
© businessNewsNewsNews.com